A Vaccine Breakthrough

This week, an unusual disagreement broke out between the president of the United States and Pope Leo XIV. The New York Times Rome bureau chief, Motoko Rich, explains why President Trump cares so much about what the pope thinks, and why it matters that they are so deeply at odds. ...  Show more

Over a month into a war with Iran that has no clear end, President Trump has enforced a blockade, which went into effect on Monday at the Strait of Hormuz. The New York Times reporters David E. Sanger, Rebecca F. Elliott and Eric Schmitt discuss the strategy behind the blockade, ...  Show more

On the same day the COVID-19 death toll surpassed 300,000 in the United States, the first vaccines are being administered, finally giving millions of Americans hope for a better future and a return to normalcy. We explore how officials expect to deliver a safe and effective vacci ...  Show more

Researchers around the world are racing to develop a vaccine against Covid-19, with more than 170 candidate vaccines now in development. Most vaccines take years of testing and additional time to produce at scale, but scientists are hoping to develop a coronavirus vaccine at reco ...  Show more

A great day for science, a bad day for Covid-19. As the first Pfizer vaccines are given to patients in the UK, the Oxford-AstraZeneca vaccine publishes its data. Adam and Fergus chat to virologist Dr Elisabetta Groppelli about how the rollout might go - and learn some Italian whi ...  Show more

Aujourd'hui, dans Covipod, nous nous penchons sur le cas des personnes que les deux doses de vaccin ne suffisent pas à protéger contre la Covid-19, et sur les mesures à prendre pour s'assurer qu'elles n'attrapent pas la maladie. Nous ferons ensuite un bref état des lieux autou ...